MAIN
©1996-2019. All Rights Reserved. Online
Journal of Bioinformatics . You may not store these pages in any form
except for your own personal use. All other usage or distribution is illegal
under international copyright treaties. Permission to use any of these pages in
any other way besides the before mentioned must
be gained in writing from the publisher. This article is exclusively
copyrighted in its entirety to OJB publications. This article may be copied
once but may not be, reproduced or re-transmitted
without the express permission of the editors. This journal
satisfies the refereeing requirements (DEST) for the Higher Education Research
Data Collection (Australia). Linking:To link to this page or any pages linking to this page
you must link directly to this page only here rather than put up your own page.
OJBTM
Online
Journal of Bioinformatics©
Volume 19
(1):13-19, 2018...
Fomecin-A
antiviral for non-structural protein NS3-4A of hepatitis C virus.
R Shanmugam1, K Mani1, B Vijay Kumar2
1BRT
lab, Department of Botany, PSG college of Arts and science Coimbatore, 2Department
of Bioinformatics, Karpagam college of Arts and science, Coimbatore, India
ABSTRACT
Shanmugam R, Mani K, Vijay Kumar B., Fomecin –A antiviral for NS3-4A of Hepatitis C virus.
Onl J Bioinform., 19 (1):13-19, 2018. Non
structural proteins of Hepatitis C virus (HCV) NS3-4A are vital for viral
polyprotein processing and replication and could be targets for treatment of
hepatitis C. We modeled a NS3/4A complex
for docking with serine protease inhibitors from NCBI and QSAR serine
proteinase Benzamidine with fungal order Aphyllophorales. Hepatitis C
viral NS34A protein sequence 1a1r was retrieved from PDB (rcsb.org) as target
sequence. NS3-4A complex was extracted from Swiss PROT viewer and Deep Viewer
used to fit raw sequence with related template sequence for similarity.
Structure bond length, angles and restraints between angles were determined by
WHATCHECK validated by Ramachandran plot. Serine protease inhibitors extracted
from NCBI were docked with NS3-4A complex by Accelerys-dstudio
to generate acceptable docking scores. Several compounds in Aphyllophorales
fungi were compared with the previously docked Benzamidine
by Accelerys-TSAR. Based on
docking scores lead compounds were selected against NS3/4A. Adsorption and
distribution were tested by ADME/TOX. Query of serine protease generated 28
inhibitors for ligands by docking with Accelrys-dstudio)
and showed that Benzamidine generated a dock score of
52.184 at one site. Templates for modeling target sequence 1a1r
extracted from SWISS-PROT were 2f9v(PDB ID) an HCV NS3 protease domain with
NS34A peptide and a ketoamide inhibitor with P1 and
P2 cyclopropylalannines, 2gvf(PDB ID) an HCV NS3-4A
protease domain complexed with a macro cyclic ketoamide
inhibitor SCH419021 and 1rgq (PDB ID), and M9A HCV Protease complex with pentapeptide keto-amide inhibitor.
Key words:
Hepatitis c virus,
Docking, TSAR, and ADME/TOX, serine protease inhibitors, WHATCHECK report, Fomecin A.
MAIN
FULL-TEXT
(SUBSCRIPTION OR PURCHASE TITLE $25USD)